chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red area around injection site going down arm, under arm, inflammation of lymph gland, redness continued over right breast, down right side to waist and partially around waist. Waist area swelled and entire area was hot. Red has not gone away yet.
Couldn't go to work; Couldn't eat; Body ache; Threw up 2 times; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (Couldn't go to work), FEEDING DISORDER (Couldn't eat), MYALGIA (Body ache), VOMITING (Threw up 2 times) and HEADACHE (Severe headache) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided by reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jul-2021, the patient experienced IMPAIRED WORK ABILITY (Couldn't go to work), FEEDING DISORDER (Couldn't eat), MYALGIA (Body ache), VOMITING (Threw up 2 times) and HEADACHE (Severe headache). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 2 dosage form (2 Tablets). At the time of the report, IMPAIRED WORK ABILITY (Couldn't go to work), FEEDING DISORDER (Couldn't eat), MYALGIA (Body ache) and VOMITING (Threw up 2 times) was resolving and HEADACHE (Severe headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that he had mild headache on 27-Jul-2021 which got serious on 28-Jul-2021. Patient felt better afterwards
Left thigh localized cellulitis, 5.5inches in diameter starting 1 day after vaccination, erythematous, slightly indurated, and warm to touch. No fever.
A minute or so after receiving both vaccinations, my son said he started blacking out, was dizzy and wanted to vomit. He tried walking over to the sink to throw up, but he fainted. He was carried over by his mother and a nurse to the bed and he was in and out of consciousness for a couple minutes. Doctor came in to assess and he was pale, sweating and his BP was 62/47 with a pulse of 58. Doctor gave him pedialyte and he stayed lying down for about 30 minutes. He was better, but had a headache for a few hours.
The day after my vaccine (and still now), I have had pain in my right neck and shoulder area, the same side as the vaccine. It feels like a really stiff neck. Starting 4 days after my vaccine, I began having pain in my right armpit. I think my lymph nodes in my armpit are swollen; it is uncomfortable and painful.
Fever Rash  Lips swelling  (left side) Eyes swelling (right)
Vaccine may not have been effective, but would not be harmful.  On 9/14/23 had Temp Excursion in Med Refrig to 0* celcius.  Reported this on 9/15/23.  Vaccines were held, Vaccine companies contacted and on 9/18/23 was told by her these vaccines were safe to give including the DTAP/IVP.   But then on 9/29/23 she contacted me again at our office and said after 2nd review, the DTAP/IPV might be INEFFECTIVE after all and should contact anyone who had dose of this to notify them possibly INEFFECTIVE, but NOT HARMFUL. and that they should come back after a month to have vaccine repeated.    Called patient's grandmother/guardian and notified of this information. She chose to bring pt in for appt scheduled  10/31/23 at 09am to have this vaccine repeated, so appt still pending.  She did not sound upset on the phone.
I tested positive or COVID-19 on 12/31/2022. I had a cough, congestion, headache, body aches, and trouble sleeping. I contacted my doctor and was prescribed 5 days' worth of PAXLOVID. I felt better after taking PAXLOVID, but not immediately. I still have a cough but feel better.
Rednes, marked swelling shoulder to elbow beginning 4-9-04. Resolved over several days.
BLOOD CLOTS; SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via a company representative via media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, therapy start date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced blood clots, and covid-19 (suspected clinical vaccination failure and suspected covid-19 infection). The reporter stated, "Got blood clots after Vax. Then covid19, out of work 18 days". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the blood clots, suspected clinical vaccination failure and suspected covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint.; Sender's Comments: V0 20220236442-COVID-19 VACCINE AD26.COV2.S-Blood clots. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable. V0 20220236442-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccine failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
The day following the shot: 0400 dry mouth (drank a lot of water, that went away), temp 98.32° 0600-1200 slept (normally awake, felt fatigued) 1200-1300 felt a massive headache coming on (drank more water, ate food), temp 99.21° 1325 felt drugged, relaxed 1331 face was completely numb 1400 headache continued getting worse 2030 feeling hot - took an aspirin (Bayer 300mg) and Benadryl (25mg) and slept it off  2 days after the shot: 0545 sore arm when raising it above the shoulder, everything else was fine  The face numbness was weird. I hadn't read about that symptom until I specifically searched for it after having it. But, everything is fine now.
Pt. reported fever 7/19/17 103 degrees F at home. Seen in walk in clinic 7/20/17 Fever 99.4. Pt. had been taking TYLENOL. Advised: fluids, rest, OTC ADVIL/TYLENOL per box instructions. Seen at doctor's office 7-21-17.
3-4 days after MMR, arm began hurting.  5-6 days after MMR, red streak appeared near injection site, 7 days after MMR, injection site became very swollen, red, painful, and hot.  Pt thinks he may have run a fever last night.  None this am.
Vesicular rash noted and swelling after IMM. Maybe related or may be viral exanthem.
Attendee received first dose Pfizer vaccine at 15:30. Attendee was directed to observation area.   At 15:40 voiced complaints of mild feeling like his throat was closing. Placed supine on the floor with feet elevated on a chair. Alert and oriented skin without pallor, sweating or rash. Denies any difficulty with breathing and respirations are even and not tachypneic.  15:45  No change in symptoms.  Attendee was administered epinephrine.  15:50  Continues to deny any shortness of breath. HR: 68   BP: 134/86   O2Sat%: 99  15:53 Starting to feel better feel of throat closing sensation almost gone.  Skin continues to be warm and dry.    16:05 -No voiced complaints- skin warm and dry.  HR: 70 BP: 116/80 O2Sat%: 98  16:20 -  EMS arrived assessed attendee and did repeated VS and offered to take him to the Emergency Room and mom declined and said she would transport.  16:30 Attendee stated that he felt better and was released to his mother, who stated that she was going to take him to the emergency room as recommended by the paramedics.  Attendee was able to walk out of clinic independently with his mother.
Nausea  Light headed, passing out  Throw up Very low BP 11:45 AM in shower. Able to move from shower chair to a wheel chair at 12:15. Into bed by 12:30.  Sleeping  3 1/2 later
Had dizziness/felt dizzy and light headed; Tingling left hand/arm feeling of pins and needle/pins and needle feeling in left hand; I had blurred vision; Headache/frontal headache; Panic attack/it was scary and strange; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program. A 32-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 06Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  Caller, called in because she received her 1st dose about a couple weeks ago and she thinks that she may have a delayed reaction to the Pfizer vaccine and had a panic attack in Apr2021, She has a 9 month daughter and her husband is deployed, she is scheduled to get the 2nd dose on 27Apr2021 but she has no child care or help, so she is seeking some advice if she can delay her 2nd shot until she have some support if that would be okay. Caller received her first dose of the Pfizer covid on 06Apr2021 and 1 week later (13Apr2021) had dizziness and tingling left hand/arm feeling of pins and needle. On the 13Apr2021 when patient had those strange experience patient had blurred vision before patient felt dizzy and light headed then the pins and needle feeling in patient's left hand then a headache; a frontal headache. Once patient took Tylenol and drank lot of water it went away. Patient have never had any symptoms like that before so it was scary and strange. Patient's doctor told patient  that patient had a delayed reaction and panic attack from the vaccine. Patient's next shot is on 27Apr2021. Patient's husband is deployed and patient had a 9 month old with no help. It was asked if patient should delay patient's 2nd shot until patient get help. Patient had a side effect after the first dose of the vaccine. It was asked if patient should get the second dose. Therapeutic measures were taken as a result of had dizziness/felt dizzy and light headed, tingling left hand/arm feeling of pins and needle/pins and needle feeling in left hand, i had blurred vision, headache/frontal headache. The outcome of event panic attack/it was scary and strange was unknown. The outcome of other events was recovered in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021457367 Same drug and different patient/event.
pt mom states noticed red raised area on rt arm where DTP was given on 5DEC97;did not see reddened area until bandaid removed;area under bandaid & all inj site area was patchy red & sl warm;sl rash on trunk;
Body aches 2/11-2/13 Chills 2/11-2/12 headache back pain 2/11-2/12 loss of appetite 2/11-2/12 swollen/painful left arm 2/11-2/15 blurry vision 2/13 Vaginal bleeding 2/15-current--- I ALREADY HAD MY PERIOD AT THE BEGINNING OF FEBRUARY.
Pt received PNEUMOVAX 23 L arm on 1/15/19 at 2pm. At 9pm site became tender. When pt awoke 1/16/19 site was red, slightly swollen, itchy, and burning. Pt returned to office 1/17/19 and was advised to apply cool compressed.
Right after the Influenza shot she developed head congestion nasal  discharge initially clear and then green and earache on left and right with tinnitis and less hearing with sore throat now cough. On the night of the 10/24/2012 there was emesis and on 10/25 only felt nauseated, no fever or chills, though feet were cold, plus fatigue but no myalgias. Patient self treatment herself with Ibuprofen and Vit. C, OTC. The night of 10/24 pt went to the emergency department and was treated with Augmentin after 1st dose -- she threw up. They also gave her Percocet with the treatment. Then got seen my MD to follow up emergency department visit, that same day/morning. MD gave her Percocet and Cefaclor for her Otitis Media and was told to call the office if she continues to be sick in one week.
Patient received PNEUMOVAX 23 on 11/12/2016. She the presented to ER with swollen, hot to touch. Presented on 11/15/16 ER prescribed KEFLEX 500 one cap 4 x daily for 10 days.
Site: Itching at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Additional Details: reaction started 2 days after shot
Husband stated that both the left and right left below the knee was affected with the right leg being the worst. He described the rash/redness as tiny bumps that did not itch. The legs were red with no swelling and no blood. As of today the left leg is clear and the right leg still looks red according to the husband. Recommended to follow up with PCP.
Original injection was received 9/10. For the first 2 days injection site was sore, but resolved quickly. On 9/15 a raised hive manifested. It was hot to the touch and the arm was exceptionally sore. It took 3 days to resolve.
Right thigh red, swollen & tender at vaccine (PROQUAD) site. Pt. previously had separate MMR & Varicella & DTaP & IPV separate.
Information has been received from a physician concerning an 8 year old pt who on 04/26/96 was vaccinated with varicella virus vaccine live. On 04/24/03 the pt experienced a a case of breakthrough varicella. There were 40 lesions. Unspecified medical attention was sought, but there was no tx or hospitalization. The pt recovered. No product quality complaint was involved. This is one out of 40 reported. Thirty nine other cases (WAES 0407USA01446 and 0409USA01855 through 0409USA01875 and 0409USA01877 through 0409USA01893) experienced breakthrough varicella ager vacciation
Since receiving the vaccine, I have had multiple site of arthritis inflammation, including both knees and my right foot. I have never had any issues with arthritis prior. The symptoms have gotten increasingly worse as well since receiving the bivalvent  Moderna booster on 9/9/2022. Lot # AS714SB. I have needed cortisone shot treatments and have my third visit to orthopedics Monday, 1/16,2023.
This literature report (initial receipt 10-Apr-2012) concerns a 59-year-old male patient. The patient had no clinical or laboratory evidence suggestive of any precipitating conditions. In 2010/2011 the patient received H1N1 influenza vaccine (manufacturer is unknown). 2 weeks after receiving H1N1 influenza vaccine the patient developed his first symptom of Guillain-Barre syndrome (GBS). Sensory symptoms included diplopia and imbalance. Motor symptoms included ophthalmoplegia and gait ataxia. A neurological examination revealed right ptosis, bilateral vertical (upward and downward) and horizontal (abduction and adduction) ophthalmoplegia, absent vestibulo-ocular reflex, generalized areflexia and severe ataxia on finger-to-nose and heel-to-shin maneuvers. The patient's cerebrospinal fluid (CSF) protein was 48mg/dl which was considered elevated. 18 days after receiving H1N1 influenza vaccine electrodiagnostic findings revealed normal nerve conduction studies of the upper and lower extremities, the facial nerve and blink reflexes. Clinical history, neurological exam, imaging studies, and serological and CSF markers excluded other etiologies of acute neuropathy such as vasculitis, vitamin deficiency, toxic neuropathy and porphyria. Treatment included intravenous immunoglobulin (IVIG) 0.4kg/day for 5 days. One week after receiving IVIG there was a slow improvement in eye movements, ataxia of gait and hands however areflexia was persistent. After 6 months the patient resumed their baseline activities. Reporter's comment: Clinical history, serological studies and CSF findings did not point to any other precipitating conditions except for the H1N1-influenza vaccination. The Brighton Collaborative Working Group established criteria for GBS in association with vaccine. The patient fulfilled level 1 diagnostic certainty criteria outlined by the work group. A relationship between the vaccine and GBS was not necessarily established.
DIARRHEA; VOMITING; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 06-MAY-2021, the subject experienced diarrhea. On 06-MAY-2021, the subject experienced vomiting. On 06-MAY-2021, the subject experienced nausea. Treatment medications (dates unspecified) included: loperamide hydrochloride, and ondansetron. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhea, vomiting, and nausea on 08-MAY-2021. This report was non-serious.
4 cm blotchy, erythema on thigh within 10 mins after MMR.
Cardiac Infraction; This spontaneous case was reported by a patient and describes the occurrence of MYOCARDIAL INFARCTION (Cardiac Infraction) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 030M20A) for COVID-19 vaccination.     No relevant medical history was provided.  Concomitant products included TICAGRELOR (BRILINTA), ACETYLSALICYLIC ACID (ASPIRIN LOW) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced MYOCARDIAL INFARCTION (Cardiac Infraction) (seriousness criteria medically significant and intervention required). At the time of the report, MYOCARDIAL INFARCTION (Cardiac Infraction) outcome was unknown.            Patient stated that they put a stent in there. Company comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Patient received an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
10/30-tested + for COVID; recovered @ home suffers from chronic anxiety after 10 mins after vac, patient thought throat was Scratchy & closing. leading to crying/hysteria/panic attack. Once attended to, all calm. 20% of who presents with throat itchy & swelling that occurred shortly after her vaccination. Pt thinks it could be a panic attack. PE - unremarkable. Plan - home with monitoring.
Throat swelling; tongue swelling; itchiness of throat; itchiness of lips; Difficulty breathing; Exhaustion; high fever; joint pain; aches; chills; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 22Mar2021 at 10:45 (at the age of 37-years-old) as single dose for COVID-19 immunisation and received the second dose for BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration in the left arm on unknown date as single dose for COVID-19 immunisation. Medical history included COVID-19; the patient had mushroom allergy. Prior to vaccination, on an unknown date the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any vaccine within four weeks prior to the COVID-19 vaccine. On 22Mar2021 (within 30 minutes of vaccination), the patient experienced aches, chills, difficulty in breathing, exhaustion, high fever, itchiness of lips, itchiness of throat, joint pain, throat swelling, tongue swelling. Therapeutic measure takes as a result all events included treatment with BENADRYL. The clinical outcome of the events aches, chills, difficulty in breathing, exhaustion, high fever, itchiness of lips, itchiness of throat, joint pain, throat swelling and tongue swelling were unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a health professional concerning a 76 year old female with drug hypersensitivity to clonidine, Codeine, tetracycline, penicillin, MACRODANTIN, MAXZIDE, propranolol hydrochloride, MEVACOR, MOTRIN, ULTRAM, RELAFEN, and CELEBREX who on 06-SEP-2007 was vaccinated intramuscularly in the left deltoid with a dose of PNEUMOVAX (Lot #655765/0061U).  There was no concomitant medication.  On 07-SEP-2007 the patient experienced injection site redness, swelling, and itchiness.  The patient was told to take BENADRYL for the injection site reaction.  There were no laboratory or diagnostic tests performed.  The patient called the physician over the weekend.  On an unspecified date the patient recovered.  The office requested a lot check.  A standard lot check investigation was performed.  All in-process quality checks for the lot number in question were satisfactory.  The lot met the requirements of the research center and was released.  Additional information has been requested.
The day after I received the vaccine, I started breaking out in hives on my right shoulder, Right elbow, and both knees. I took 50mg of Benadryl as needed and while the Benadryl was in effect, the hives went away.  I had hives the evening of the 15th to the evening of the 16th. However, on the 17th, so far I have not had any hives break out.
Information has been received from a medical assistant concerning a patient of unknown age. The medical assistant reported that the patient received one dose of PEDVAXHIB (indication and total dosage not provided) on 04-JUN-2015 that was not stored properly. No adverse effects were reported. Additional information is not expected.